Rapport Therapeutics Statistics

Total Valuation

RAPP has a market cap or net worth of $366.79 million. The enterprise value is $62.99 million.

Market Cap	366.79M
Enterprise Value	62.99M

Important Dates

The last earnings date was Tuesday, March 11, 2025, before market open.

Earnings Date	Mar 11, 2025
Ex-Dividend Date	n/a

Share Statistics

RAPP has 36.50 million shares outstanding. The number of shares has increased by 1,277.25% in one year.

Current Share Class	36.50M
Shares Outstanding	36.50M
Shares Change (YoY)	+1,277.25%
Shares Change (QoQ)	+0.61%
Owned by Insiders (%)	6.81%
Owned by Institutions (%)	51.14%
Float	14.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.20
P/TBV Ratio	1.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 35.34, with a Debt / Equity ratio of 0.00.

Current Ratio	35.34
Quick Ratio	34.82
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -35.09% and return on invested capital (ROIC) is -22.86%.

Return on Equity (ROE)	-35.09%
Return on Assets (ROA)	-22.07%
Return on Invested Capital (ROIC)	-22.86%
Return on Capital Employed (ROCE)	-27.13%
Revenue Per Employee	n/a
Profits Per Employee	-$1.13M
Employee Count	69
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	12.48
200-Day Moving Average	19.31
Relative Strength Index (RSI)	45.15
Average Volume (20 Days)	373,712

Short Selling Information

The latest short interest is 1.66 million, so 4.55% of the outstanding shares have been sold short.

Short Interest	1.66M
Short Previous Month	1.51M
Short % of Shares Out	4.55%
Short % of Float	11.27%
Short Ratio (days to cover)	11.75

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-83.06M
Pretax Income	n/a
Net Income	-78.31M
EBITDA	-82.22M
EBIT	-83.06M
Earnings Per Share (EPS)	-$3.78

Full Income Statement

Balance Sheet

The company has $305.28 million in cash and $1.48 million in debt, giving a net cash position of $303.80 million or $8.32 per share.

Cash & Cash Equivalents	305.28M
Total Debt	1.48M
Net Cash	303.80M
Net Cash Per Share	$8.32
Equity (Book Value)	305.43M
Book Value Per Share	8.35
Working Capital	301.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$64.83 million and capital expenditures -$2.41 million, giving a free cash flow of -$67.23 million.

Operating Cash Flow	-64.83M
Capital Expenditures	-2.41M
Free Cash Flow	-67.23M
FCF Per Share	-$1.84

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,277.25%
Shareholder Yield	-1,277.25%
Earnings Yield	-21.35%
FCF Yield	-18.33%

Analyst Forecast

The average price target for RAPP is $37.33, which is 271.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$37.33
Price Target Difference	271.44%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2